Charles D. Hyman’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$4.26M Sell
8,357
-33
-0.4% -$16.2K 0.24% 66
2024
Q1
$4.15M Hold
8,390
0.23% 70
2023
Q4
$4.42M Buy
8,390
+434
+5% +$231K 0.26% 64
2023
Q3
$4.01M Buy
7,956
+117
+1% +$57.6K 0.26% 65
2023
Q2
$3.77M Buy
7,839
+55
+0.7% +$26.9K 0.24% 70
2023
Q1
$3.68M Buy
7,784
+158
+2% +$76.2K 0.25% 73
2022
Q4
$4.04M Hold
7,626
0.28% 66
2022
Q3
$3.85M Sell
7,626
-65
-0.8% -$34.2K 0.3% 62
2022
Q2
$3.95M Buy
7,691
+415
+6% +$208K 0.29% 66
2022
Q1
$3.71M Hold
7,276
0.23% 70
2021
Q4
$3.65M Sell
7,276
-9
-0.1% -$4.07K 0.23% 72
2021
Q3
$2.85M Buy
7,285
+209
+3% +$86.6K 0.2% 79
2021
Q2
$2.83M Sell
7,076
-18
-0.3% -$7.18K 0.2% 81
2021
Q1
$2.64M Buy
7,094
+36
+0.5% +$12.5K 0.19% 80
2020
Q4
$2.48M Buy
7,058
+144
+2% +$48.3K 0.2% 80
2020
Q3
$2.16M Buy
6,914
+971
+16% +$298K 0.19% 82
2020
Q2
$1.75M Buy
5,943
+5,022
+545% +$1.44M 0.17% 85
2020
Q1
$230K Hold
921
0.03% 163
2019
Q4
$271K Buy
+921
New +$241K 0.03% 178

Other funds holding UNH

Charles D. Hyman's UNH Position: Q2 2024 in Review

Charles D. Hyman reduced its UnitedHealth (UNH) stake by 0.39% in Q2 2024, selling an estimated $16.2K and leaving 8,357 shares worth $4.26M. The position accounts for 0.24% of the portfolio, ranked #66.

Charles D. Hyman first reported a position in UNH in Q4 2019 and has held it in 19 quarters since. The position peaked at $4.42M in Q4 2023. 3,394 funds tracked by Wall St. Rank hold UNH as of Q2 2024.

  • Charles D. Hyman held 8,357 shares of UnitedHealth worth $4.26M as of Q2 2024.
  • Charles D. Hyman sold 33 UnitedHealth shares in Q2 2024, an estimated $16.2K.
  • UnitedHealth made up 0.24% of Charles D. Hyman's portfolio in Q2 2024, its #66 holding.
  • Charles D. Hyman first reported a position in UnitedHealth in Q4 2019 and has held it in 19 quarters since.
  • Charles D. Hyman's UnitedHealth position peaked at $4.42M in Q4 2023.
  • 3,394 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2024.

Based on Charles D. Hyman's 13F filing for Q2 2024, filed 25 Jul 2024.